Document:

EXHIBIT 10.1

 

CREDIT AGREEMENT 

 

This CREDIT AGREEMENT,
dated as of September 10, 2019 (as amended, modified or supplemented from time to time, this “Agreement”), is
entered into by and between AMYRIS, INC., a Delaware corporation (the “Company”), and [_____________]
(the “Lender”).

 

RECITALS

    A.  Subject
to the terms and conditions hereof, the Lender has agreed to purchase from the Company, and the Company has agreed to sell to the
Lender, an unsecured promissory note (the “Note”) in the form attached hereto as Exhibit A having
an aggregate principal amount of [_______] Dollars ($[______]).

 

AGREEMENT 

 

    NOW THEREFORE,
in consideration of the representations, warranties, and conditions set forth below, the parties hereto, intending to be legally
bound, hereby agree as follows:

 

    1.  Purchase
and Sale of the Note.  The sale and purchase of the Note (the “Closing”) shall take place
at such place and time as the Company and the Lender may determine, but in no event later than September 10, 2019. At the Closing,
the Company will deliver to the Lender the Note, against receipt by the Company of [________] Dollars ($[_______]) in immediately
available funds. The Note will be registered in the Lender’s name in the Company’s records.

 

   2.  Representations
and Warranties of the Company.  The Company represents and warrants to the Lender as of the date hereof and as
of the Closing that:

 

		(a)	Due Incorporation, Qualification, etc.  The Company (i) is a corporation
duly organized, validly existing and in good standing under the laws of Delaware; (ii) has the power and authority to own,
lease and operate its properties and carry on its business as now conducted; and (iii) is duly qualified, licensed to do business
and in good standing as a foreign corporation in each jurisdiction where the failure to be so qualified or licensed could reasonably
be expected to have a Material Adverse Effect.

 

		(b)	Authority.  The execution, delivery and performance by the Company of this Agreement
and the Note and the consummation by the Company of the transactions contemplated hereby and thereby have been duly authorized
by all necessary corporate actions on the part of the Company.

 

		(c)	Enforceability.  This Agreement and the Note have been duly executed and delivered
by the Company and constitute a legal, valid and binding obligation of the Company, enforceable against the Company in accordance
with its respective terms, except in each case as may be limited by bankruptcy, insolvency or other laws of general application
relating to or affecting the enforcement of creditors’ rights generally and general principles of equity.

 

     

     

    

 

		(d)	Non-Contravention.  The execution and delivery by the Company of this Agreement
and the Note and the performance and consummation by the Company of the transactions contemplated hereby and thereby do not and
will not (i) violate the certificate of incorporation or bylaws of the Company or any judgment, order, writ, decree, statute,
rule or regulation applicable to the Company; (ii) violate any provision of, or result in the breach or the acceleration
of, or entitle any other Person to accelerate (whether after the giving of notice or lapse of time or both), any mortgage, indenture,
agreement, instrument or contract to which the Company is a party or by which it is bound except to the extent such violation,
breach or acceleration could not reasonably be expected to result in a Material Adverse Effect; or (iii) result in the creation
or imposition of any lien upon any property, asset or revenue of the Company or the suspension, revocation, impairment, forfeiture,
or nonrenewal of any permit, license, authorization or approval applicable to the Company, its business or operations, or any of
its assets or properties except to the extent such suspension, revocation, impairment, forfeiture or nonrenewal could not reasonably
be expected to have a Material Adverse Effect. The Company is not in breach of any mortgage, indenture, agreement, instrument or
contract to which the Company is a party or by which it is bound except to the extent such breach could not reasonably be expected
to result in a Material Adverse Effect.

 

		(e)	Approvals.  No consent, approval, order or authorization of, or registration, declaration
or filing with, any governmental authority or other Person is required in connection with the execution and delivery by the Company
of this Agreement and the Note and the performance and consummation by the Company of the transactions contemplated hereby and
thereby, except for those already obtained or those that will be obtained prior to the Closing.

 

		(f)	Tax Returns and Payments. The Company has timely filed all required tax returns and
reports, and the Company has timely paid all foreign, federal, state and local taxes, assessments, deposits and contributions owed
by the Company except to the extent such taxes are being contested in good faith by appropriate proceedings promptly instituted
and diligently conducted, so long as such reserve or other appropriate provision, if any, as shall be required in conformity with
GAAP shall have been made therefor.

 

		(g)	Litigation. There are no actions or proceedings pending or threatened in writing by or against
the Company except for such actions or proceedings that, individually or in the aggregate, would not reasonably be expected to
result in a Material Adverse Effect.

 

		(h)	Full Disclosure. No written representation, warranty or other statement of the Company in
any certificate or written statement given to Lender by the Company in connection with this Agreement or the Note, as of the date
such representation, warranty, or other statement was made, contains any untrue statement of a material fact or omits to state
a material fact necessary to make the statements contained in the certificates or written statements not misleading in light of
the circumstances under which they were made.

 

   3.  Representations
and Warranties of the Lender.  The Lender represents and warrants to the Company as of the date hereof and as
of the Closing that:

 

		(a)	Due Incorporation, Qualification, etc.  The Lender (i) is duly organized,
validly existing and in good standing under the laws of its jurisdiction of formation; and (ii) has all requisite power to
execute and deliver this Agreement and to carry out and perform its obligations under the terms of this Agreement.

 

		(b)	Authority.  The execution, delivery and performance by the Lender of this Agreement
and the consummation by the Company of the transactions contemplated hereby have been duly authorized by all necessary corporate
actions on the part of the Lender.

 

    	 	2	 

     

    

 

		(c)	Enforceability.  The Lender has full legal capacity, power and authority to execute
and deliver this Agreement and to perform its obligations hereunder. This Agreement is a valid and binding obligation of the Lender,
enforceable in accordance with its terms, except as limited by bankruptcy, insolvency or other laws of general application relating
to or affecting the enforcement of creditors’ rights generally and general principles of equity.

 

		(d)	Securities Law Compliance.   The Lender is purchasing the Note for its own account
for investment, not as a nominee or agent, and not with a view to, or for resale in connection with, the distribution thereof.
Lender has received or has had full access to all of the information necessary and appropriate to make an informed investment decision.
The Lender is an accredited investor as such term is defined in Rule 501 of Regulation D under the Securities Act of
1933, as amended. The Lender acknowledges that it can bear the economic risk of the investment the Note.

 

		(e)	Approvals. No consent, approval, order or authorization of, or registration, declaration
or filing with, any governmental authority or other Person is required in connection with the execution and delivery by the Lender
of this Agreement and the performance and consummation by the Lender of the transactions contemplated hereby, except for those
already obtained.

 

		(f)	Non-Contravention.  The execution and delivery by the Lender of this Agreement
and the performance and consummation by the Lender of the transactions contemplated hereby do not and will not (i) violate
the organizational documents of the Lender or any judgment, order, writ, decree, statute, rule or regulation applicable to
the Lender; or (ii) violate any agreement to which the Lender is a party or by which it is bound.

 

		(g)	Information Non-Reliance.

 

(i)The Lender represents and
warrants that (i) it has carefully reviewed such information as it and its advisers deem necessary to make its decision to invest
in the Note, (ii) has the ability to make, and has made, an informed decision as to the risks and merits of its investment in the
Note on the terms set forth in this Agreement, and (iii) has made its own decision to consummate the transactions contemplated
hereunder based exclusively on its own independent review, its financial experience, and consultations with such advisers as it
deemed necessary. Without limiting the generality of the foregoing, the Lender acknowledges that neither the Company nor any of
its affiliates or representatives is acting as a fiduciary or financial or investment adviser to the Lender, or has given the Lender
any investment advice, opinion or other information on whether an investment in the Note is prudent. The Lender agrees it is not
relying on the Information (as defined below), or any other information other than the express representations set forth in this
Agreement.

 

(ii) The Lender acknowledges
that the Company and its affiliates and representatives possess material nonpublic information regarding the Company not known
to the Lender that may impact the value of the Note (the “Information”), that the Information is not disclosed
in the Company’s public disclosures or its filings with the U.S. Securities and Exchange Commission (the “Commission”),
and that the Company is not disclosing the Information to the Lender and that the Company and its affiliates and representatives
have not made, and are not making, any representation with respect to any Information. The Lender understands, based on its experience,
the disadvantage to which the Lender is subject due to the disparity of information between the Company and the Lender and the
fact that the Information is not being disclosed to the Lender. The Lender acknowledges and agrees that, notwithstanding such disparity,
it has deemed it appropriate to enter into this Agreement and to consummate the transactions contemplated hereunder. The Lender
acknowledges the possibility that the Information may be material to a determination of a fair value for the Note and that value
may be substantially different from the price being paid by the Lender for the Note hereunder.

 

    	 	3	 

     

    

 

(iii) The Lender agrees that
neither the Company nor any of its affiliates or representatives shall have any liability to the Lender whatsoever due to or in
connection with the non-disclosure of the Information, and the Lender hereby irrevocably waives any claim that it might have based
on the failure of the Company to disclose the Information. The Lender hereby irrevocably and unconditionally expressly releases,
discharges and waives, to the fullest extent permitted by law, any and all claims, rights, causes of action, suits, obligations,
debts, demands, liabilities, controversies, costs, expenses, fees or damages of any kind (including, but not limited to, any and
all claims alleging violations of federal or state securities laws, common-law fraud or deceit, breach of fiduciary duty, negligence
or otherwise), whether directly, derivatively, representatively or in any other capacity, that it may have or hereafter acquire
against the Company, or any of its affiliates and their respective officers, employees, agents and controlling persons, relating
to the purchase and sale of the Note, including the existence or non-existence of any Information, the Lender’s inability
to review such Information or any failure to disclose such Information.

 

(iv) The Lender understands
that the Company relies on the accuracy and truth of the foregoing representations, warranties, acknowledgements and agreements
in entering into this Agreement and performing its obligations hereunder, and would not engage in the transactions contemplated
by this Agreement in the absence of such representations, warranties, acknowledgements and agreements, and the Lender hereby consents
to such reliance.

 

(v) Notwithstanding the forgoing,
nothing in this Section 3(g) shall be deemed to limit or restrict the Lender’s rights or remedies with respect to any breach
or violation by the Company of any of its representations, warranties or covenants contained in this Agreement or the Note, or
to constitute an admission by the Company that any information is material or is otherwise required to be disclosed to any person.

 

    4.  Conditions
to Obligations of the Lender.  The Lender’s obligations hereunder are subject to the fulfillment, on or
prior to the Closing, of all of the following conditions, any of which may be waived in whole or in part by the Lender:

 

		(a)	Representations and Warranties.  The representations and warranties made by the
Company in Section 2 hereof shall have been true and correct when made, and shall be true and correct as of the Closing.

 

		(b)	Governmental Approvals and Filings.  The Company shall have obtained all governmental
approvals required in connection with the sale and issuance of the Note.

 

		(c)	Legal Requirements.  At the Closing, the sale and issuance by the Company, and
the purchase by the Lender, of the Note shall be legally permitted by all laws and regulations to which the Lender or the Company
is subject.

 

		(d)	Transaction Documents.  The Company shall have duly executed and delivered to
the Lender this Agreement, the Note and the Warrant.

 

    	 	4	 

     

    

 

    5.  Conditions to Obligations
of the Company.  The Company’s obligations hereunder are subject to the fulfillment, on or prior to the
Closing, of all of the following conditions, any of which may be waived in whole or in part by the Company:

 

		(a)	Representations and Warranties.  The representations and warranties made by the Lender in Section 3 hereof
shall be true and correct when made, and shall be true and correct as of the Closing.

 

		(b)	Governmental Approvals and Filings.  The Lender shall have obtained all governmental
approvals required in connection with the sale and issuance of the Note.

 

		(c)	Legal Requirements.  At the Closing, the sale and issuance by the Company, and
the purchase by the Lender, of the Note shall be legally permitted by all laws and regulations to which the Lender or the Company
are subject.

 

		(d)	Purchase Price.  The Lender shall have delivered to the Company [______] Dollars ($[_____]) in immediately
available funds.

 

    6.   Definitions.  As
used in this Agreement, the following capitalized terms have the following meanings:

 

“Closing”
shall have the meaning set forth in Section 1 hereof.

 

“Code”
shall have the meaning set forth in Section 7(l) hereof.

 

“Default”
means the occurrence of any event or condition which, upon notice of passage of time, would constitute an Event of Default.

 

“Event
of Default” shall have the meaning set forth in the Note.

 

“Form
8-K” shall have the meaning set forth in Section 7(j) hereof.

 

“Form
8-K Filing” shall have the meaning set forth in Section 7(j) hereof.

 

“GAAP”
shall mean shall mean generally accepted accounting principles in the United States of America as in effect from time to time as
set forth in the opinions and pronouncements of the Accounting Principles Board and the American Institute of Certified Public
Accountants and the statements and pronouncements of the Financial Accounting Standards Board which are applicable to the circumstances
as of the date of determination consistently applied.

 

“Material
Adverse Effect” means a material adverse effect, individually or in the aggregate, (i) upon the business, properties,
tangible and intangible assets, liabilities, operations, prospects, financial condition or results of operation of the Company,
(ii) the ability of the Company to perform the Obligations in accordance with the terms of this Agreement or the Note or (iii) or
the ability of Lender to enforce any of its rights or remedies with respect to the Obligations.

 

“Obligations”
means all obligations of the Company under this Agreement or the Note including all loans, advances, debts, liabilities and obligations,
howsoever arising, owed by the Company to the Lender under this Agreement and the Note of every kind and description (whether
or not evidenced by any note or instrument and whether or not for the payment of money), now existing or hereafter arising under
or pursuant to the terms of the Note, including all principal, interest, fees, charges, expenses, attorneys’ fees and costs
and accountants’ fees and costs chargeable to and payable by the Company thereunder, in each case, whether direct or indirect,
absolute or contingent, due or to become due, and whether or not arising after the commencement of a proceeding under Title 11
of the United States Code (11 U.S.C. Section 101 et seq.), as amended from time to time (including post-petition interest)
and whether or not allowed or allowable as a claim in any such proceeding.

 

    	 	5	 

     

    

 

“Person”
shall mean and include an individual, a partnership, a corporation (including a business trust), a joint stock company, a limited
liability company, an unincorporated association, a joint venture or other entity or a governmental authority.

 

“Principal
Amount” shall have the meaning set forth in Section 7(l) hereof.

 

“Warrant”
means the Common Stock Purchase Warrant, issued on September [__], 2019, for the purchase of up to [_______] Warrant Shares (as
such term is defined in the Warrant).

 

    7.  Miscellaneous.  

 

		(a)	Waivers and Amendments.  Any provision of this Agreement may be amended, waived
or modified only upon the written consent of the Company and the Lender.

 

		(b)	Governing Law.  This Agreement and all actions arising out of or in connection
with this Agreement shall be governed by and construed in accordance with the laws of the State of New York, without regard to
the conflicts of law provisions of the State of New York.

 

		(c)	Survival.  The representations, warranties, covenants and agreements made herein shall survive the execution
and delivery of this Agreement.

 

		(d)	Successors and Assigns.  Subject to the restrictions on transfer described in
Section 7(e) below, the rights and obligations of the Company and the Lender hereunder and under the Note shall be binding
upon and inure to the benefit of the successors, assigns, heirs, administrators and transferees of the parties.

 

		(a)	Assignment by the Company; Assignment by the Lender.  Neither this Agreement nor
the Note nor any of the rights, interests or obligations hereunder or thereunder may be assigned, by operation of law or otherwise,
in whole or in part, by the Company without the prior written consent of the Lender. The Lender will not assign, by operation of
law or otherwise, this Agreement or the Note or any of its rights, interests or obligations hereunder or thereunder without the
prior written consent of the Company, other than to an affiliate of the Lender or to a managed account or other entity with respect
to which the Lender or any of its affiliates has investment control or authority.

 

		(b)	Entire Agreement.  This Agreement and the Note constitute the full and entire
understanding and agreement between the parties relating to the subject matter hereof and thereof and supersede any previous written
or verbal agreements between the parties with regard to the subject matter hereof and thereof.

 

		(c)	Notices.  Any notice, request or other communication required or permitted hereunder
shall be in writing and shall be deemed to have been duly given if delivered personally or by commercial delivery service, or sent
via telecopy (receipt confirmed) to the parties at the following addresses or telecopy numbers (or at such other address or telecopy
numbers for a party as shall be specified by like notice):

 

    	 	6	 

     

    

 

If to the Company, to:

 

Amyris, Inc.

5885 Hollis St., Ste. 100

Emeryville, CA 94608

Attention: General Counsel

 

If to the Lender, to:

 

[

 

 

 

]

 

		(d)	Severability of this Agreement.  If any provision of this Agreement shall be judicially
determined to be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall
not in any way be affected or impaired thereby.

 

		(e)	Choice of Forum; Service of Process; Jury Trial Waiver.

 

		(i)	The Company and the Lender irrevocably consent and submit to the exclusive jurisdiction of the
courts of the State of New York and the United States District Court for the Southern District of New York, whichever the Lender
may elect, and waive any objection based on venue or forum non conveniens with respect to any action instituted therein arising
under this Agreement or the Note or in any way connected with or related or incidental to the dealings of the parties hereto in
respect of this Agreement or the Note or the transactions related hereto or thereto, in each case whether now existing or hereafter
arising, and whether in contract, tort, equity or otherwise, and agree that any dispute with respect to any such matters shall
be heard only in the courts described above (except that the Lender shall have the right to bring any action or proceeding against
the Company or its property in the courts of any other jurisdiction which the Lender deems necessary or appropriate in order to
enforce its rights against the Company).

 

		(ii)	The Company hereby waives personal service of any and all process upon it and consents that all
such service of process may be made by certified mail (return receipt requested) directed to its address set forth herein and service
so made shall be deemed to be completed five (5) days after the same shall have been so deposited in the U.S. mails, postage prepaid
and return receipt requested, or, at the Lender’s option, by service upon the Company in any other manner provided under
the rules of any such courts.

 

		(iii)	THE COMPANY AND THE LENDER EACH HEREBY WAIVES ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND,
ACTION OR CAUSE OF ACTION ARISING UNDER THIS AGREEMENT OR ANY OF THE OTHER FINANCING AGREEMENTS OR IN ANY WAY CONNECTED WITH OR
RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO IN RESPECT OF THIS AGREEMENT OR THE NOTE OR THE TRANSACTIONS RELATED
HERETO OR THERETO IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY OR OTHERWISE. THE
COMPANY AND THE LENDER EACH HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION OR CAUSE OF ACTION SHALL BE DECIDED
BY COURT TRIAL WITHOUT A JURY AND THAT THE COMPANY AND THE LENDER MAY FILE A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE
OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY.

 

    	 	7	 

     

    

 

		(iv)	The Lender shall not have any liability to the Company (whether in tort, contract, equity or otherwise)
for losses suffered by the Company in connection with, arising out of, or in any way related to the transactions or relationships
contemplated by this Agreement or the Note, or any act, omission or event occurring in connection herewith, unless it is determined
by a final and non-appealable judgment or court order of competent jurisdiction binding on the Lender, that the losses were the
result of acts or omissions constituting gross negligence or willful misconduct of its obligations under this Agreement or the
Note. The Company: (i) certifies that neither the Lender nor any representative, agent or attorney acting for or on behalf of the
Lender has represented, expressly or otherwise, that the Lender would not, in the event of litigation, seek to enforce any of the
waivers provided for in this Agreement or the Note and (ii) acknowledges that in entering into this Agreement and the Note, the
Lender is relying upon, among other things, the waivers and certifications set forth in this Section 7(i) and elsewhere herein
and therein.

 

		(f)	Form 8-K Filing. The Company shall, no later than 5:30 pm Eastern Time on the business day
immediately following the Closing, file with the Commission a Current Report on Form 8-K (as prescribed by the Exchange Act) disclosing
(i) the transactions contemplated hereunder and pursuant to the Warrant and (ii) any other financing transaction, securities issuance
or other material event required to be disclosed on Form 8-K, in each case of which the Lender has knowledge, which has occurred,
or is occurring on or as of the date of the Closing (and not previously publicly disclosed by the Company) (the “Form
8-K”). The Company shall provide a draft of the Form 8-K to the Lender for review and comment a reasonable time prior
to the filing thereof (the “Form 8-K Filing”).

 

		(g)	Disclosure Representation Letter. The Company shall, promptly following the Form 8-K Filing
and on the date thereof, execute and deliver to the Lender a written representation as to the absence of material non-public information
provided to the Lender by the Company, with such exceptions thereto as the Company may deem appropriate, if any (without any such
exception constituting either the Company's or the Lender's agreement or concession that the information referenced in any such
exception constitutes material non-public information).

 

    	 	8	 

     

    

 

		(h)	Issue Price. The Company and the Lender acknowledge and agree, solely for federal income
tax purposes, that (i) the issuance of the Note and the Warrant for the principal amount of the Note (the “Principal Amount”)
constitutes an “investment unit” within the meaning of Section 1273(c)(2) of the U.S. Internal Revenue Code (the “Code”),
(ii) the issue price of the investment unit (within the meaning of Treasury Regulations Section 1.1273-2(h)) is equal to the Principal
Amount, (iii) such issue price should be allocated $[________] to the Note and $[______] to the Warrant, and (iv) the foregoing
allocation is based on the relative fair market values of the Note and the Warrant. Unless otherwise required pursuant to applicable
law, the Company and the Lender shall prepare and file their respective federal income tax returns (and any information returns
and other related statements required by the Code or any Treasury regulations, whether proposed, temporary or final) in a manner
which is consistent with the allocation of the respective issue prices of the Warrant and the Note pursuant to this Agreement,
including but not limited to the calculation of the amount, if any, of “original issue discount,” as defined in Section
1273(a) of the Code, on the Note. Nothing in this Section 7(l) shall be interpreted, alone or in conjunction with any other agreement
to which the Company and the Lender are parties, (i) to modify the rate or amount of interest payable on the Note, (ii) to reduce
the outstanding principal amount of the Note, (iii) to alter the amount of the exercise price of the Warrant, or (iv) to limit
or impair in any way the rights of the Lender under this Agreement, the Warrant or the Note.

 

		(i)	Modification Obligation. The Company shall not amend or otherwise modify any provision of
that certain Credit Agreement, entered into on August 28, 2019 with Foris Ventures, LLC, or of the promissory note issued pursuant
thereto, or grant any waiver thereunder, in each case in favor of the counterparty thereto or holder thereof, or issue any additional
consideration or benefit pursuant thereto or in connection therewith, including any increase in interest rate, covenant modification,
grant of equity or rights to acquire equity, without, in each case, concurrently therewith, amending or modifying this Agreement
and the Note, as applicable, or granting a waiver, or issuing additional consideration or benefit, on the same terms for the benefit
of the Lender (or its assignees).

 

		(j)	Counterparts.  This Agreement may be executed in any number of counterparts, each
of which shall be an original, but all of which together shall be deemed to constitute one instrument.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT
BLANK]

 

 

 

 

 

 

 

    	 	9	 

     

    

 

IN WITNESS WHEREOF,
the parties have caused this Agreement to be duly executed and delivered by their proper and duly authorized officers as of the
date and year first written above.

 

	 	COMPANY:
	 	 	 	 
	 	AMYRIS, INC.
	 	 	 	 
	 	By:	 	 
	 	Name:	 	 
	 	Title:	 	 
	 	 	 	 
	 	LENDER:	 
	 	 	 	 
	 	[_____________________]
	 	 	 	 
	 	By:	 	 
	 	Name:	 	 
	 	Title:	 	 

 

 

 

 

 

 

 

 

 

 

 

 

 

     

     

    

 

EXHIBIT A

FORM OF NOTE 

 

 

 

 

 

 

 

 

 

 

 

 

     

     

    

 

AMYRIS, INC.

 

PROMISSORY NOTE 

 

	$[_________]	 	                       Issuance date: September [__], 2019

    

Amyris,
Inc., a Delaware corporation (the “Company”), for value received, hereby promises to pay to [____________],
or registered assigns (the “Holder”), the principal sum of [________] Dollars ($[_______]), or such lesser amount
as shall then equal the outstanding principal amount hereunder, on January 1, 2023 (the “Maturity Date”) and
to pay interest thereon, from the date of this Note, or from the most recent date to which interest has been paid on this Note,
quarterly on March 31, June 30, September 30 and December 31 in each year, commencing December 31, 2019, at the rate of twelve
percent (12.0%) per annum (calculated on a simple interest basis) until the Maturity Date or the earlier repayment or other satisfaction
of this Note.

         

 Payment
of the principal of this Note shall be made upon the surrender of this Note to the Company at its chief executive office (or such
other office within the United States as shall be designated by the Company to the holder hereof) (the “Designated Office”)
on the Maturity Date or such earlier date in accordance with the terms of this Note. All amounts payable in cash with respect to
this Note shall be made by wire transfer to the holder, provided that if the holder shall not have furnished wire
instructions in writing to the Company no later than the business day immediately prior to the date on which the Company makes
such payment, such payment may be made by U.S. dollar check mailed to the address of the holder as such address shall appear in
the Company register. Notwithstanding anything contained herein or in any common stock purchase warrant issued by the Company to
the Holder and outstanding as of the date hereof (each, a “Warrant”) to the contrary, the Holder shall be permitted,
upon written notice to the Company, to pay the exercise price for any shares of the Company’s common stock, par value $0.0001
per share, issuable upon the exercise of any Warrant (the “Warrant Shares”) by surrendering to the Company all,
or any portion, of this Note and all or such portion of the outstanding amount under this Note, as applicable, shall be cancelled
in exchange for the payment of the exercise price for such Warrant Shares and, if the Holder surrenders less than all of this Note,
the Company shall promptly thereafter issue to the Holder a new promissory note for the remaining amount under this Note.

 

This
Note was issued pursuant to the Credit Agreement, dated as of September [__], 2019 (as amended from time to time, the “Agreement”),
by and between the Company and the original holder of this Note and is subject to provisions of the Agreement. Capitalized terms
used but not otherwise defined herein shall have the meaning given to such terms in the Agreement.

 

1.  Redemption.  This
Note is subject to redemption, in whole or from time to time in part (in any amount that is an integral multiple of $1,000), upon
not less than five (5) days’ prior written notice in the manner provided in Section 4(b) hereof, at the election of the Company,
at a redemption price of 100% of the amount hereof, together with accrued and unpaid interest to, but excluding, the redemption
date.

 

2.  Certain Covenants.
Until the Obligations hereunder are paid or otherwise satisfied in full:

 

		(a)	The Company will maintain or cause to be maintained its corporate or other organizational existence
and good standing in its jurisdiction of incorporation and maintain its qualification in each jurisdiction where the failure to
so qualify would reasonably be expected to have a Material Adverse Effect.

 

     

     

    

 

		(b)	The Company will comply with all applicable statutes, regulation and orders of, and all applicable
restrictions imposed by, all governmental bodies, domestic or foreign, in respect of the conduct of its business and the ownership
of its property, other than those the noncompliance with which would not have, and which would not reasonably be expected to have,
a Material Adverse Effect.

 

		(c)	The Company will cause the proceeds of the loans evidenced under this Note to be used solely (a)
as working capital and (b) to fund the Company’s general business requirements, and not for personal, family or household
purposes.

 

		(d)	The Company will execute any further instruments and take any further action as the Holder reasonably
requests to effect the purposes of this Note or the Agreement.

 

    3.  Events
of Default.  

 

		(a)	“Event of Default”, wherever used herein, means any one of the following events
(whatever the reason for such Event of Default and whether it shall be voluntary or involuntary or be effected by operation of
law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental
body):

 

		(i)	default in the payment of any amount upon this Note when it becomes due and payable;

 

		(ii)	default in the performance, or breach, of any covenant of the Company herein (other than a default
in the performance or breach of which is specifically dealt with elsewhere in this Section 3(a)) and continuance of such default
or breach for a period of 10 days;

 

		(iii)	the commencement against the Company of an involuntary case or proceeding under any applicable
federal or state bankruptcy, insolvency, reorganization or other similar law or of any other case or proceeding to be adjudicated
bankrupt or insolvent and such case or proceeding is not dismissed or stayed within 45 days;

 

		(iv)	the commencement by the Company of a voluntary case or proceeding under any applicable federal
or state bankruptcy, insolvency, reorganization or other similar law or of any other case or proceeding to be adjudicated a bankrupt
or insolvent, or the consent by the Company to the entry of a decree or order for relief in respect of the Company in an involuntary
case or proceeding under any applicable federal or state bankruptcy, insolvency, reorganization or other similar law or to the
commencement of any bankruptcy or insolvency case or proceeding against either the Company, or the filing by either the Company
of a petition or answer or consent seeking reorganization or similar relief under any applicable federal or state law, or the consent
by it to the filing of such petition or to the appointment of or taking possession by a custodian, receiver, liquidator, assignee,
trustee, sequestrator or other similar official of the Company or of any substantial part of its property, or the making by either
the Company of an assignment for the benefit of creditors, or the admission by either the Company in writing of its inability to
pay its debts generally as they become due, or the taking of corporate action by the Company in furtherance of any such action;

 

     

     

    

 

		(v)	The Company or any Person acting for the Company makes any representation, warranty, or other statement
now or later in this Note or the Agreement or in any writing delivered to the Holder or to induce the Holder in connection with
this Note, the Agreement or any other document entered into in connection with this Note or the Agreement or to enter this Note,
the Agreement or any other document entered into in connection with this Note or the Agreement, and such representation, warranty,
or other statement is incorrect in any material respect when made;

 

		(vi)	at any time, any “person” or “group” (as such terms are used in Sections
13(d) and 14(d) of the Securities Exchange Act of 1934 (the “Exchange Act”)), shall become, or obtain rights
(whether by means of warrants, options or otherwise) to become, the “beneficial owner” (as defined in Rules 13(d)-3
and 13(d)-5 under the Exchange Act), directly or indirectly, of fifty percent (50.0%) or more of the ordinary voting power for
the election of directors of the Company (determined on a fully diluted basis);

 

		(vii)	any portion of the Company’s assets are attached or seized, or a levy is filed against any
such assets, or a judgment or judgments is/are entered for the payment of money, individually or in the aggregate, of at least
$10,000,000, or the Company is enjoined or in any way prevented by court order from conducting any part of its business and such
judgment shall remain undischarged or unvacated, unbonded or unstayed for a period in excess of forty-five (45) days; or

 

		(viii)	the Company and/or any Subsidiary, individually or in the aggregate, fails to pay, when due, or
within any applicable grace period, any payment with respect to any indebtedness in excess of $10,000,000 due to any third party
(other than, with respect to unsecured indebtedness only, payments contested by the Company and/or such Subsidiary (as the case
may be) in good faith by proper proceedings and with respect to which adequate reserves have been set aside for the payment thereof
in accordance with GAAP) or is otherwise in breach or violation of any agreement for monies owed or owing in an amount in excess
of $10,000,000, which breach or violation results in the acceleration of amounts due thereunder.

 

(b)   
Upon the occurrence and during the continuance of an Event of Default, the Holder may (a) declare all Obligations hereunder
immediately due and payable (but if an Event of Default described in Section 3(a)(iii) or 3(a)(iv) occurs all Obligations hereunder
are immediately due and payable without any action by the Holder) and (b) exercise all rights and remedies available to the Holder
under this Note, the Agreement or at law or equity. The Company will give the Holder notice, within five (5) business days of the
occurrence thereof, of any Event of Default of which it is or becomes aware. Such notice shall be given in the manner provided
in Section 4(b).

 

		(c)	Upon the occurrence of and during the continuation of any Event of Default, the interest rate applicable
to the Obligations shall be automatically increased, without need for further action by the Holder, by five percent (5%) per annum
(the “Default Rate”) with respect to the principal then outstanding and all other Obligations then outstanding
(including, to the extent permitted by applicable law, all past due interest) (whether before or after any judgment and whether
or not acceleration or demand for payment has been made). The Company acknowledges that the cost and expense to the Holder due
to an Event of Default are difficult to ascertain and that the Default Rate is fair and reasonable compensation for this.

 

     

     

    

 

4.  Other.  

 

(a)   
No provision of this Note shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay
the principal of and interest on this Note at the times and places herein prescribed or to repay or otherwise satisfy this Note
as herein provided.

 

(b)   
The Company will give prompt written notice to the Holder of any change in the location of the Designated Office. Any notice
to the Company or to the Holder shall be given in the manner set forth in the Agreement.

 

(c)   
The transfer of this Note is registrable on the register maintained by the Company upon surrender of this Note for registration
of transfer at the Designated Office, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory
to the Company duly executed by, the holder hereof or such holder’s attorney duly authorized in writing, and thereupon one
or more new notes, of authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee
or transferees. Such securities are issuable only in registered form without coupons in denominations of $1,000 and any integral
multiple thereof. No service charge shall be made for any such registration of transfer, but the Company may require payment of
a sum sufficient to recover any tax or other governmental charge payable in connection therewith. Prior to due presentation of
this Note for registration of transfer, the Company and any agent of the Company may treat the Person in whose name this Note is
registered as the owner thereof for all purposes, whether or not this Note be overdue, and neither the Company nor any such agent
shall be affected by notice to the contrary.

 

(d)   
This Note shall be governed by and construed in accordance with the internal laws of the State of New York, without regard
to the conflicts of law provisions of the State of New York.

 

[The remainder
of this page is intentionally left blank]

 

 

 

 

     

     

    

 

   IN WITNESS WHEREOF,
the Company has caused this Note to be duly executed.

 

Dated: September [__], 2019

 

	 	Amyris, Inc.	 
	 	 	 	 
	 	By:	 	 
	 	Name:	 	 
	 	Title:EXHIBIT 10.2

 

 

STANDSTILL AGREEMENT

 

This Standstill Agreement
(this “Agreement”), dated as of September 10, 2019, is entered into by and between Amyris, Inc., a Delaware
corporation (the “Company”), on the one hand, and Schottenfeld Opportunities Fund II, L.P., Phase

Five Partners, LP and Koyote Trading, LLC
(each, an “Investor” and collectively, the “Investors”), on the other hand.

 

RECITALS

 

WHEREAS, the
Company and the Investors are parties to those certain Credit Agreements, each dated as of the date hereof (as such agreements
may be amended, restated or modified from time to time, the “Credit Agreements”), pursuant to which the Investors
have agreed to make unsecured term loans to the Company in an aggregate principal amount of $12,500,000;

 

WHEREAS, in
connection with the entry into the Credit Agreements, the Company has agreed to issue to the Investors warrants (each, a “Warrant”
and collectively, the “Warrants”) to purchase up to an aggregate of 3,205,128 shares (the “Warrant
Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at
an exercise price of $3.90 per share, in each case subject to adjustment as set forth in the Warrants, each with an exercise term
of two years from issuance; and

 

WHEREAS, in
order to induce the Company to enter into the Credit Agreements and issue the Warrants, the Company and the Investors desire to
enter into this Agreement.

 

NOW, THEREFORE,
for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties to this Agreement,
intending to be legally bound, hereby agree as follows:

 

1. Definitions.
For purposes of this Agreement:

 

“Agreement”
has the meaning set forth in the Preamble.

 

“Affiliate”
means, with respect to any Person, any other Person that is directly or indirectly controlled by such Person, where “control”
and derivative terms mean the possession, directly or indirectly, of the power to direct or cause the direction of the management
or policies of a Person, whether through the ownership of voting securities, by contract, or otherwise.

 

“Board” means
the board of directors of the Company.

 

“Common Stock”
has the meaning set forth in the Recitals.

 

“Company” has
the meaning set forth in the Preamble.

 

“Credit Agreements”
has the meaning set forth in the Recitals.

 

“Exchange Act”
has the meaning set forth in Section 2(b).

 

“Investor” has
the meaning set forth in the Preamble.

 

“Investor Group”
means, collectively, each Investor and their respective Affiliates.

 

“Person” means
any individual, corporation, limited or general partnership, limited liability company, limited liability partnership, trust, association,
joint venture, governmental entity, or other entity.

 

“Representative”
means, as to any Person, such Person’s Affiliates, and its and their respective directors, officers, employees, managing
members, general partners, agents and consultants (including attorneys, financial advisors and accountants), solely in their capacity
as representatives acting at the direction of and on behalf of such Person.

 

“Warrant” has
the meaning set forth in the Recitals.

 

“Warrant Shares”
has the meaning set forth in the Recitals.

 

     

     

    

 

2. Investor Group
Covenants. Unless approved in advance in writing by the Board, no member of the Investor Group, nor any of their respective
Representatives in their capacities as such, will (and the Investors will cause each member of the Investor Group and their respective
Representatives acting in such capacities not to), directly or indirectly:

 

(a)                
acquire (or propose or agree to acquire), of record or beneficially, on the open market or otherwise, by purchase or otherwise,
any loans, debt securities, equity securities, or assets of the Company or any of its subsidiaries, or rights or options to acquire
interests in any of the Company’s loans, debt securities, equity securities, or assets, except that the Investor Group shall
be permitted to (a) purchase the Warrant Shares pursuant to the exercise of the Warrants and (b) acquire equity securities as provided
in Section 3 below;

 

(b)               
make any statement or proposal to the Board or to any of the Company’s shareholders regarding, or make any public announcement,
proposal, or offer (including any “solicitation” of “proxies” as such terms are defined or used in Regulation
14A of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) with respect to, or otherwise solicit,
seek or offer to effect (including, for the avoidance of doubt, indirectly by means of communication with the press or media):
(a) any business combination, merger, tender offer, exchange offer, or similar transaction involving the Company or any of its
subsidiaries; (b) any restructuring, recapitalization, liquidation, or similar transaction involving the Company or any of its
subsidiaries; (c) any acquisition of any of the Company’s loans, debt securities, equity securities or assets, or rights
or options to acquire interests in any of the Company’s loans, debt securities, equity securities, or assets; (d) any proposal
to seek representation on the Board or otherwise seek to control or influence the management, Board, or policies of the Company;
(e) make any request or proposal to waive, terminate, or amend the provisions of this Section 2; or (f) make any proposal,
arrangement, or other statement that is inconsistent with the terms of this Section 2;

 

(c)                
instigate, encourage, or assist any third party (including forming a “group” (as defined in Rule 13d-5(b)(1) of the
Exchange Act) with any such third party) to do, or enter into any discussions, negotiations, understandings or agreements with
any third party with respect to, any of the actions set forth in Section 2(b) above; or

 

(d)               
take any action that would reasonably be expected to require the Company, any Investor or any of their respective Affiliates to
make a public announcement regarding any of the actions set forth in Section 2(b) above;

 

provided, that, for the
avoidance of doubt, the restrictions set forth in this Section 2 shall not prevent or otherwise restrict any Investor from
exercising its rights as an unsecured creditor with respect to any bankruptcy, insolvency, reorganization, restructuring, recapitalization,
liquidation or similar transaction or proceeding with respect to the Company, provided that no member of the Investor Group, nor
any of their respective Representatives, initiated the transaction or proceeding in violation of this Section 2.

 

3. Exception
to Investor Group Covenants. Notwithstanding anything to the contrary in this Agreement, the Investor Group shall be permitted
(as an exception to the restrictions in Section 2) to acquire in the open market or otherwise, from time to time, equity
securities of the Company, or rights or options to acquire interests in any of the Company’s equity securities, provided
that, after giving effect to such acquisition, the Investor Group would beneficially own (as determined under Section 13(d) of
the Exchange Act) no more than 6.99% of the Common Stock then outstanding.

 

4. Transfer of Warrants.
Notwithstanding anything contained in its Warrant to the contrary, each Investor hereby agrees that it will not transfer, dispose
of, pledge, loan or otherwise convey any registered or beneficial ownership interest in its Warrant to any third party without
the prior written consent of the Company, which may be granted or withheld in the Company’s sole discretion.

 

5. Termination.
This Agreement, including the restrictions set forth in Section 2, shall terminate and be of no further force and effect
on the date on which no Investor beneficially owns any Warrant Shares or, if earlier, as of the date the Company enters into a
definitive agreement with a person or “group” of persons (as defined in Rule 13d-5(b)(1) of the Exchange Act) involving
the direct or indirect acquisition of all or a majority of the Company’s equity securities or all or substantially all of
the Company’s assets, or the date as of which any such person or group, with the prior approval of the Board, commences a
tender offer for all or a majority of the Company's equity securities.

 

6. Miscellaneous.

 

    	 	2	 

     

    

 

(a)                
Successors and Assigns. The terms and conditions of this Agreement shall inure to the benefit of and are binding upon the
respective successors and permitted assignees of the parties. Nothing in this Agreement, express or implied, is intended to confer
upon any party other than the parties hereto or their respective successors and permitted assignees any rights, remedies, obligations
or liabilities under or by reason of this Agreement, except as expressly provided herein.

 

(b)               
Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which
together shall be deemed to be one and the same agreement. A signed copy of this Agreement delivered by facsimile, e-mail or other
means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this Agreement.

 

(c)                
Notices. All notices, requests, consents, claims, demands, waivers and other communications under this Agreement shall be
in writing and shall be deemed to have been given (a) when delivered by hand (with written confirmation of receipt); (b) when received
by the addressee if sent by a nationally recognized overnight courier (receipt requested); (c) on the date sent by facsimile or
e-mail (with confirmation of transmission) if sent during normal business hours of the recipient, and on the next business day
if sent after normal business hours of the recipient; or (d) on the third day after the date mailed, by certified or registered
mail, return receipt requested, postage prepaid. Any communication to the Investors or the Company shall be sent in accordance
with the contact information set forth below (or at such other contact information as specified in a notice given in accordance
with this Section 6(c)).

 

	If to the Company:	 	Amyris, Inc.
	 	 	5885 Hollis Street, Suite 100
	 	 	Emeryville, CS 94608
	 	 	Attention: General Counsel
	 	 	 
	 	 	 
	If to any Investor:	 	800 Third Avenue, 10th Floor
	 	 	New York, NY 10022
	 	 	Attention: Richard Schottenfeld

 

(d)               
Amendments and Waivers. Any term of this Agreement may be amended, modified or terminated and the observance of any term
of this Agreement may be waived (either generally or in a particular instance, and either retroactively or prospectively) only
with the written consent of each of the parties hereto.

 

(e)                
Severability. In case any one or more of the provisions contained in this Agreement is for any reason held to be invalid,
illegal or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provision
of this Agreement.

 

(f)                 
Entire Agreement. This Agreement, the Credit Agreements, the Warrants, and the other documents and agreements delivered
pursuant to the Credit Agreements constitute the sole and entire agreement of the parties to this Agreement with respect to the
subject matter contained herein and therein, and supersede all prior and contemporaneous understandings and agreements, both written
and oral, with respect to such subject matter.

 

(g)               
Specific Performance. Each party acknowledges and agrees that each party hereto will be irreparably damaged in the event
any of the provisions of this Agreement are not performed by the parties in accordance with their specific terms or are otherwise
breached. Accordingly, it is agreed that each party to this Agreement shall be entitled to seek an injunction to prevent breaches
of this Agreement, and to seek specific enforcement of this Agreement and its terms and provisions.

 

(h)               
Governing Law; Submission to Jurisdiction; Waiver of Jury Trial.

 

i.                       
This Agreement shall be governed by and construed in accordance with the internal laws of the State of New York without giving
effect to any choice or conflict of law provision or rule (whether of the State of New York or any other jurisdiction).

 

    	 	3	 

     

    

 

ii.                       
ANY LEGAL SUIT, ACTION OR PROCEEDING ARISING OUT OF OR BASED UPON THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY MAY BE
INSTITUTED IN THE FEDERAL COURTS OF THE UNITED STATES OF AMERICA OR THE COURTS OF THE STATE OF NEW YORK IN EACH CASE LOCATED IN
THE CITY AND COUNTY OF NEW YORK, AND EACH PARTY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF SUCH COURTS IN ANY SUCH SUIT,
ACTION OR PROCEEDING. SERVICE OF PROCESS, SUMMONS, NOTICE OR OTHER DOCUMENT BY MAIL TO SUCH PARTY’S ADDRESS SET FORTH IN
THIS AGREEMENT SHALL BE EFFECTIVE SERVICE OF PROCESS FOR ANY SUIT, ACTION OR OTHER PROCEEDING BROUGHT IN ANY SUCH COURT. THE PARTIES
IRREVOCABLY AND UNCONDITIONALLY WAIVE ANY OBJECTION TO THE LAYING OF VENUE OF ANY SUIT, ACTION OR ANY PROCEEDING IN SUCH COURTS
AND IRREVOCABLY WAIVE AND AGREE NOT TO PLEAD OR CLAIM IN ANY SUCH COURT THAT ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN ANY
SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.

 

iii.                       
EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND
DIFFICULT ISSUES AND, THEREFORE, EACH SUCH PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY
IN RESPECT OF ANY LEGAL ACTION ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY
TO THIS AGREEMENT CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE,
THAT SUCH OTHER PARTY WOULD NOT SEEK TO ENFORCE THE FOREGOING WAIVER IN THE EVENT OF A LEGAL ACTION, (B) SUCH PARTY HAS CONSIDERED
THE IMPLICATIONS OF THIS WAIVER, (C) SUCH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (D) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO
THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 6(h)(iii).

 

(i)                 
Delays or Omissions. No delay or omission to exercise any right, power, or remedy accruing to any party under this Agreement,
upon any breach or default of any other party under this Agreement, shall impair any such right, power, or remedy of such non-breaching
or non-defaulting party, nor shall it be construed to be a waiver of or acquiescence to any such breach or default, or to any similar
breach or default thereafter occurring, nor shall any waiver of any single breach or default be deemed a waiver of any other breach
or default theretofore or thereafter occurring. All remedies, whether under this Agreement or by law or otherwise afforded to any
party, shall be cumulative and not alternative.

 

[SIGNATURE PAGE FOLLOWS]

 

 

 

 

 

    	 	4	 

     

    

 

IN WITNESS WHEREOF,
the parties have executed this Agreement as of the date first written above.

 

	 	COMPANY:	 
	 	 	 	 
	 	AMYRIS, INC.	 
	 	 	 	 
	 	By:	/s/ Kathleen Valiasek	 
	 	Name: Kathleen Valiasek	 
	 	Title: Chief Business Officer	 
	 	 	 	 
	 	INVESTORS:	 
	 	 	 	 
	 	SCHOTTENFELD OPPORTUNITIES FUND II, L.P.
	 	By: Winchester Holdings, L.L.C., its General Partner
	 	 	 	 
	 	By: 	/s/ Richard Schottenfeld	 
	 	Name: Richard Schottenfeld	 
	 	Title: Manager	 
	 	 	 	 
	 	PHASE FIVE PARTNERS, LP
	 	By: Phase Five Holdings, LLC, its General Partner
	 	 	 	 
	 	By:	/s/ Richard Schottenfeld	 
	 	Name: Richard Schottenfeld	 
	 	Title: Manager	 
	 	 	 	 
	 	KOYOTE TRADING, LLC
	 	By: Koyote Capital Group, LLC, its Manager
	 	 	 	 
	 	By:	/s/ Richard Schottenfeld	 
	 	Name: Richard Schottenfeld	 
	 	Title: Manager	 

 

 

 

 

 

 

 

[Standstill Agreement Signature Page]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}]]